Selected article for: "bile acid and fecal bile acid"

Title: 2017 ACVIM Forum Research Abstract Program
  • Document date: 2017_6_15
  • ID: ri2w5iby_339
    Snippet: In conclusion, this study identified differences in the fecal microbiota as well as fecal lactate and bile acid concentrations between dogs with EPI and healthy control dogs. CD25, also known as interleukin-2 receptor a (IL-2Ra), is a 55 kDa transmembrane cytokine receptor, primarily expressed by activated T cells, regulatory T cells (Tregs), and some types of cancer cells. In humans, increased expression of membrane-bound CD25 has been reported .....
    Document: In conclusion, this study identified differences in the fecal microbiota as well as fecal lactate and bile acid concentrations between dogs with EPI and healthy control dogs. CD25, also known as interleukin-2 receptor a (IL-2Ra), is a 55 kDa transmembrane cytokine receptor, primarily expressed by activated T cells, regulatory T cells (Tregs), and some types of cancer cells. In humans, increased expression of membrane-bound CD25 has been reported in patients with autoimmune or inflammatory diseases, during transplant rejection, and some types of neoplasia. A soluble form of CD25 (sCD25) is generated by proteolytic cleavage and has a molecular mass of 45 kDa. Elevated serum concentrations of sCD25 have been reported in human patients with the aforementioned conditions. A positive correlation has been reported between the membrane expression of CD25 and the serum concentration of sCD25. In vitro, activated T cells and Tregs have been shown to shed sCD25, therefore high concentrations of serum sCD25 are thought to be reflective of a sustained immune activation. Moreover, sCD25 has been used as a biomarker to help characterize disease progression, prognosis, and treatment in humans. Thus, the aim of this study was to establish and analytically validate a radioimmunoassay for the measurement of sCD25 in canine serum.

    Search related documents:
    Co phrase search for related documents
    • cancer cell and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cancer cell and high concentration: 1, 2, 3, 4, 5, 6, 7
    • cancer cell and human patient: 1, 2, 3, 4
    • cancer cell type and disease progression: 1
    • canine serum and fecal microbiota: 1
    • canine serum and high concentration: 1, 2
    • control dog and healthy control dog: 1
    • cytokine receptor and disease progression: 1, 2, 3, 4, 5, 6, 7, 8
    • disease progression and fecal microbiota: 1
    • disease progression and high concentration: 1, 2, 3
    • disease progression and human patient: 1, 2, 3
    • high concentration and human patient: 1, 2